selected scholarly activity
-
chapters
- Arthritis: A Diagnostic Approach. 33-44. 2015
-
conferences
- Late Breaking Abstract - Benralizumab reduces eosinophils and ANCA in sputum in EGPA. pa5372. 2024
- Urine and Plasma Complement Ba Levels During Disease Flares in Patients With Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis. Kidney International Reports. 2421-2427. 2023
- Ocular manifestations of ANCA-associated vasculitis. Rheumatology. 2517-2524. 2023
- Characteristics of Relapse of Individuals With ANCA-Associated Vasculitis Enrolled in the PEXIVAS Trial. Journal of Rheumatology. 20-20. 2023
- The Effects of Initial Treatment on Relapse of ANCA-Associated Vasculitis in the PEXIVAS Trial. Journal of Rheumatology. 21-21. 2023
- Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis. Arthritis Care and Research. 1806-1812. 2022
- Markers of Neutrophil Activation in Patients with ANCA-associated Vasculitis and Large-vessel Vasculitis. Arthritis & Rheumatology. 979-981. 2022
- Outcome Measures in Patients with Neurologic Involvement in ANCA-associated Vasculitis: Data from Multicenter Longitudinal Observational Study. Arthritis & Rheumatology. 870-872. 2022
- The Association Between Age of Diagnosis and Disease Characteristics and Damage in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis & Rheumatology. 1024-1027. 2022
- Ocular Manifestations of ANCA-associated Vasculitis. Journal of Rheumatology. 772-772. 2022
- Radiological Validation of a Novel MRI Reporting System for Axial Spondyloarthritis. Journal of Rheumatology. 785-785. 2022
- A Polyclonal Airway Autoimmune Response Is Associated with Clinical Indices of Asthma Severity. American Journal of Respiratory and Critical Care Medicine. 2022
- DURATION OF STEROID THERAPY AND TEMPORAL ARTERY BIOPSY POSITIVITY IN GIANT CELL ARTERITIS: A RETROSPECTIVE COHORT STUDY. Irish Journal of Medical Science. S33-S34. 2022
- Urine and Plasma Complement Ba Levels During Flares of Nephritis in Patients with ANCA-Associated Vasculitis. Journal of the American Society of Nephrology. 449-449. 2021
- Neurologic Involvement in ANCA-associated Vasculitis: Data from Multicenter Longitudinal Observational Study. Arthritis & Rheumatology. 856-858. 2021
- Neutrophil Extracellular Trap Formation in Patients with Vasculitis. Arthritis & Rheumatology. 3906-3907. 2021
- A Review of PAH Screening Practices of Patients in the Canadian Scleroderma Research Group Registry: Is It Time to Revise the Guidelines?. Journal of Rheumatology. 1183-1183. 2021
- Changes in Disease Features Do Not Differ Between SSc Patients Who Did versus Did Not Undergo Annual PAH Screening: Data from the Canadian Scleroderma Research Group Registry. Journal of Rheumatology. 1116-1117. 2021
- Radiological Validation of a Novel MRI Reporting System for Axial Spondyloarthritis. Journal of Rheumatology. 1116-1116. 2021
- Vasculitis in Patients With Rheumatoid Arthritis: A Descriptive Study. Journal of Rheumatology. 1176-1177. 2021
- Efficacy of leflunomide in the treatment of vasculitis. Clinical and Experimental Rheumatology. 114-118. 2021
- Azathioprine Compared to Mycophenolate Mofetil Treatment in Patients with Interstitial Lung Disease Associated with Systemic Sclerosis. American Journal of Respiratory and Critical Care Medicine. 2021
- Azathioprine Compared to Mycophenolate Mofetil Treatment in Patients with Interstitial Lung Disease Associated with Systemic Sclerosis. TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD. a1915-a1915. 2021
- Clinical Indices of Autoimmunity Do Not Predict Sputum Autoantibodies in Patients with Severe Eosinophilic Asthma: A Prospective Study. American Journal of Respiratory and Critical Care Medicine. 2021
- Care Gap in Patients with Systemic Sclerosis with CXR Findings Suggestive of Fibrosis. Arthritis & Rheumatology. 2020
- Prevalence of Thyroid Disease Among Patients with Vasculitis. Arthritis & Rheumatology. 2020
- Thyroid Disease in Patients with ANCA-Associated Vasculitis. Arthritis & Rheumatology. 2020
- Impact of diabetes, angiotensin‐converting enzyme inhibitor or angiotensin II receptor blocker use, and statin use on presentation and outcomes in patients with giant cell arteritis. International Journal of Rheumatic Diseases. 1233-1239. 2020
- Biopsy-positive Versus Negative Giant Cell Arteritis: Clinical Presentation, Predictive Factors and Effect of Extra-long Biopsy Length. Journal of Rheumatology. 1123-1123. 2020
- Development of a Patient-Centred Iloprost and Alprostadil Infusion Information Sheet for Patients with Scleroderma. Journal of Rheumatology. 1086-1086. 2020
- Inter-Rater Reliability of the Bhavsar-Khalidi Clinical Scoring System for Risk Stratification of Giant Cell Arteritis. Journal of Rheumatology. 1059-1060. 2020
- Pituitary Disease in Granulomatosis with Polyangiitis: An International Collaborative Case Series. Journal of Rheumatology. 1089-1089. 2020
- Rationalizing Temporal Artery Magnetic Resonance Angiography in the Diagnosis of Giant Cell Arteritis. Journal of Rheumatology. 1076-1076. 2020
- Sacroiliitis and Spondyloarthritis in Patients with Giant Cell Arteritis - More than a Chance Occurrence. Journal of Rheumatology. 1050-1051. 2020
- The Effect of Pregnancy on the Progression of Scleroderma. Journal of Rheumatology. 1086-1087. 2020
- FRI0258 CUMULATIVE INCIDENCE, SURVIVAL AND PREDICTORS OF PULMONARY HYPERTENSION IN SYSTEMIC SCLEROSIS SUBSETS: PAH IS NOT INCREASED IN LIMITED VS DIFFUSE PATIENTS BY ADJUSTED COMPETING RISK ANALYSIS. Annals of the Rheumatic Diseases. 713-713. 2020
- Infliximab Therapy in Patients with Refractory Sarcoidosis: A Multicenter Retrospective Review. American Journal of Respiratory and Critical Care Medicine. 2020
- Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis. Rheumatology. 2203-2211. 2019
- Assessments of Quality of Life in Patients with Eosinophilic Granulomatosis with Polyangiitis. Arthritis & Rheumatology. 2019
- Clinical Manifestations of Patients with Eosinophilic Granulomatosis with Polyangiitis in a Large North American Cohort. Arthritis & Rheumatology. 2019
- Comparison of Arterial Patterns of Disease in Takayasu's Arteritis and Giant Cell Arteritis. Arthritis & Rheumatology. 2019
- Comparison of Patient Self-reported Data to Physician-driven Cohorts in Patients with Eosinophilic Granulomatosis with Polyangiitis. Arthritis & Rheumatology. 2019
- Rationalizing the Use of MRI of the Scalp Arteries in the Diagnosis of Giant Cell Arteritis Through Multivariable Predictive Modelling. Arthritis & Rheumatology. 2019
- The Cumulative Burden of Damage for Patients with Eosinophilic Granulomatosis with Polyangiitis. Arthritis & Rheumatology. 2019
- Scleroderma and Pregnancy: Worse Pulmonary Outcomes Following Pregnancy in Patients from the CSRG Registry. Journal of Rheumatology. 858-858. 2019
- Severe Ischemic Events in Takayasu Arteritis: A Canadian Retrospective Cohort. Journal of Rheumatology. 787-788. 2019
- YouTube as a Platform for Narrative Medicine: A Novel Approach to Promote Empathy and Awareness for Patients with Chronic Disease. Journal of Rheumatology. 766-767. 2019
- A CLINICAL SCORING SYSTEM FOR RISK STRATIFICATION OF GIANT CELL ARTERITIS. Rheumatology. 2019
- DIFFUSE ALVEOLAR HEMORRHAGE, PULMONARY NODULES AND INFILTRATES IN GRANULOMATOSIS POLYANGIITIS AND MICROSCOPIC POLYANGIITIS. A COHORT STUDY OF 736 PATIENTS. Rheumatology. 60-60. 2019
- FACTORS ASSOCIATED WITH DISEASE PROGRESSION IN PATIENTS WITH MYELOPEROXIDASE-ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-RELATED PULMONARY FIBROSIS. Rheumatology. 2019
- UTILIZATION OF CANADIAN HEALTHCARE ADMINISTRATIVE DATABASES TO ACCURATELY IDENTIFY CASES OF ANCA-ASSOCIATED VASCULITIS. Rheumatology. 2019
- Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis. Arthritis & Rheumatology. 2077-2086. 2018
- Candidate Biomarkers in ANCA-Associated Vasculitis Identified Using a Proteomic Approach. Arthritis & Rheumatology. 2018
- Discovery and Validation of Novel Disease Subsets in 806 Patients with Takayasu's Arteritis across Four International Cohorts. Arthritis & Rheumatology. 2018
- Plasma iC3b Level As a Biomarker of Disease Relapse in ANCA-Associated Vasculitis. Arthritis & Rheumatology. 2018
- Screening of Patients with Adult-Onset Idiopathic Polyarteritis Nodosa for Deficiency of Adenosine Deaminase 2. Arthritis & Rheumatology. 2018
- Biopsy-positive versus Negative Giant Cell Arteritis: Clinic Presentation and Predictive Factors. Journal of Rheumatology. 1061-1062. 2018
- Use of a Clinical Scoring System in Risk Stratifying Patients with Suspected Giant Cell Arteritis. Journal of Rheumatology. 1044-1045. 2018
- Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis. PLoS ONE. e0205768-e0205768. 2018
- Damage and Predictors of Damage in Takayasu's Arteritis. Arthritis & Rheumatology. 2017
- Discrepancies between Clinical- and Imaging-Based Assessments of Disease Activity in Takayasu's Arteritis. Arthritis & Rheumatology. 2017
- Longitudinal Angiographic Findings in Patients with Takayasu's Arteritis. Arthritis & Rheumatology. 2017
- Markers of Inflammation and Patient-Reported Measures As Predictors of Relapse in Giant Cell Arteritis. Arthritis & Rheumatology. 2017
- Pituitary Disease and Granulomatosis with Polyangiitis: A Collaborative Canadian Case Series and Review of the Literature. Arthritis & Rheumatology. 2017
- Pulmonary Manifestations in Microscopic Polyangiitis and Granulomatosis with Polyangiitis: A Multicenter Cohort Analysis. Arthritis & Rheumatology. 2017
- The Effect on Health-Related Quality of Life of Treatment for Remission Maintenance in ANCA-Associated Vasculitis Beyond 18 Months. Arthritis & Rheumatology. 2017
- Urinary Epidermal Growth Factor and Monocyte Chemoattractant Protein-1 As Biomarkers of Renal Involvement in ANCA-Associated Vasculitis. Arthritis & Rheumatology. 2017
- Sputum anti-neutrophil cytoplasmic antibodies in eosinophilic granulomatosis and polyangiitis patients with respiratory involvement. Allergy. European Journal of Allergy and Clinical Immunology. 756-756. 2017
- A Case Series of Two Presentations of Skull Base Inflammatory Pseudotumor Sparing the Orbit and a Review of the Literature Focusing on Steroids and Immunosuppressive Induction Regimens. Journal of Rheumatology. 886-886. 2017
- Pulmonary Arterial Hypertension and Pulmonary Fibrosis Screening in Systemic Sclerosis in Clinical Practice: Choosing Wisely or Missed Opportunities?. Journal of Rheumatology. 881-881. 2017
- A RANDOMIZED DOUBLE-BLIND TRIAL OF ABATACEPT AND GLUCOCORTICOIDS FOR THE TREATMENT OF TAKAYASU'S ARTERITIS. Rheumatology. 49-49. 2017
- ARTERIAL LESIONS IN GIANT CELL ARTERITIS. Rheumatology. 58-59. 2017
- DISCREPANCIES BETWEEN CLINICAL- AND IMAGING-BASED ASSESSMENTS OF DISEASE ACTIVITY IN TAKAYASU'S ARTERITIS. Rheumatology. 45-45. 2017
- IDENTIFICATION OF FUNCTIONAL AND EXPRESSION POLYMORPHISMS ASSOCIATED WITH RISK FOR ANTI-NEUTROPHIL CYTOPLASMIC AUTOANTIBODY-ASSOCIATED VASCULITIS. Rheumatology. 23-24. 2017
- LATE-ONSET RELAPSE IN PATIENTS WITH SYSTEMIC VASCULITIS. Rheumatology. 107-108. 2017
- PATIENT REPORTED OUTCOMES AS PREDICTORS OF FLARES IN TAKAYASU ARTERITIS. Rheumatology. 51-51. 2017
- PREVALENCE OF IMMUNOFLUORESCENT DEPOSITS IN ANCA ASSOCIATED VASCULITIS. Rheumatology. 38-38. 2017
- SPUTUM ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) IN EOSINOPHILIC GRANULAMATOSIS AND POLYANGIITIS (EGPA). Rheumatology. 17-17. 2017
- URINARY EPIDERMAL GROWTH FACTOR AS A BIOMARKER OF RENAL INVOLVEMENT IN ANCA-ASSOCIATED VASCULITIS. Rheumatology. 2017
- UTILITY OF MEASUREMENTS OF URINARY SOLUBLE CD163 & MCP1 IN THE IDENTIFICATION OF SUBTLE RENAL FLARES IN ANCA VASCULITIS. Rheumatology. 39-39. 2017
- Identification And Validation Of Unique And Shared M2 Macrophage Biomarkers Between Murine Models And Human Disease Using Bioinformatic Gene Expression Analysis. American Journal of Respiratory and Critical Care Medicine. 2017
- The Hsp90 Inhibitor Radicicol As A Bioinformatically-Derived Drug For M2 Macrophage Phenotype Inhibition. American Journal of Respiratory and Critical Care Medicine. 2017
- A Randomized Double-Blind Trial of Abatacept and Glucocorticoids for the Treatment of Takayasu's Arteritis. Arthritis & Rheumatology. 2016
- Arterial Lesions in Giant Cell Arteritis. Arthritis & Rheumatology. 2016
- Fatigue and Physical Functioning in Patients with Giant Cell Arteritis. Arthritis & Rheumatology. 2016
- Health-Related Quality of Life in Giant Cell Arteritis. Arthritis & Rheumatology. 2016
- Late-Onset Relapse in Patients with Systemic Vasculitis. Arthritis & Rheumatology. 2016
- New Insights into the Pathogenesis of Giant Cell Arteritis through a Genome-Wide Association Study. Arthritis & Rheumatology. 2016
- The Utility of Patient-Reported Outcomes in Predicting Disease Activity in Patients with Takayasu's Arteritis. Arthritis & Rheumatology. 2016
- Utility of Measurements of Urinary Soluble CD163 & MCP-1 in the Identification of Subtle Renal Flares in ANCA-Associated Vasculitis. Arthritis & Rheumatology. 2016
- Fecal Incontinence and Association with Bowel Dysfunction in Systemic Sclerosis: A Canadian Multicenter Study. Journal of Rheumatology. 1151-1151. 2016
- Giant Cell Arteritis Presenting with Bilateral Vertebral Artery Stenosis - A Case Report and Review of the Literature. Journal of Rheumatology. 1214-1215. 2016
- Leukotriene Receptor Antagonist Therapy Associated Eosinophilic Granulomatosis with Polyangiitis: A Case and Literature Review. Journal of Rheumatology. 1244-1244. 2016
- Recurrence of Scleroderma Renal Crisis in Transplanted Kidney Leading to Graft Failure. Journal of Rheumatology. 1198-1198. 2016
- A Randomized Double-Blind Trial of Abatacept and Glucocorticoids for the Treatment of Giant Cell Arteritis. Arthritis & Rheumatology. 2015
- Administration of Patient Reported Outcome Measurement Information System (PROMIS) Instruments By Computer Adaptive Testing in Patients with Systemic Vasculitis. Arthritis & Rheumatology. 2015
- Anticytokine Autoantibody Profiling in Five Types of Systemic Vasculitis. Arthritis & Rheumatology. 2015
- Damage Assessment in Giant Cell Arteritis. Arthritis & Rheumatology. 2015
- Damage Assessment in Takayasu's Arteritis. Arthritis & Rheumatology. 2015
- Fecal Incontinence and Association with Bowel Dysfunction in Systemic Sclerosis: A Canadian Multicenter Study. Arthritis & Rheumatology. 2015
- Safety and Tolerability of Pirfenidone in Patients with Systemic Sclerosis Interstitial Lung Disease. Arthritis & Rheumatology. 2015
- Using Exome Sequencing to Identify Novel Genetic Associations with Granulomatosis with Polyangiitis Susceptibility. Arthritis & Rheumatology. 2015
- Safety and tolerability of pirfenidone (PFD) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD)–The LOTUSS study. European Respiratory Journal. 2015
- Inflammatory Pseudotumour of the Skull Base: A Case Report and Review of the Literature. Journal of Rheumatology. 1329-1329. 2015
- Prevalence, Severity and Impact of Fecal Incontinence in Systemic Sclerosis: Preliminary Results of a Cross-Sectional Study. Journal of Rheumatology. 1326-1327. 2015
- T Cell Epitopes Stimulating TGF beta in Patients with Systemic Sclerosis: Towards a Vaccine. Journal of Rheumatology. 1315-1316. 2015
- Training the Rheumatologists of Tomorrow: The Learners Experience. Journal of Rheumatology. 1284-1285. 2015
- Training the Rheumatologists of Tomorrow: The WOMAC Experience. Journal of Rheumatology. 1310-1311. 2015
- Vasculitis in Patients with Inflammatory Bowel Diseases: A Study of 32 Patients and Systematic Review of the Literature. Journal of Rheumatology. 1279-1279. 2015
- SAT0433 Safety and Tolerability of Pirfenidone in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease – the Lotuss Study. Annals of the Rheumatic Diseases. 816.2-816. 2015
- Safety And Tolerability Of Pirfenidone In Patients With Systemic Sclerosis-Associated Interstitial Lung Disease - The Lotuss Study. American Journal of Respiratory and Critical Care Medicine. 2015
- Accuracy of High Resolution MRI of Scalp Arteries for the Diagnosis of Giant Cell Arteritis: Results of a Prospective Study.. Arthritis & Rheumatology. S390-S391. 2014
- An Immunochip Study Confirms a Strong Contribution of HLA Class I and II Genes in the Susceptibility to Giant Cell Arteritis.. Arthritis & Rheumatology. S388-S389. 2014
- Biomarkers of Disease Activity in Vasculitis.. Arthritis & Rheumatology. S354-S354. 2014
- Genetic Susceptibility Loci of Idiopathic Interstitial Pneumonitis Do Not Represent Risk for Systemic Sclerosis.. Arthritis & Rheumatology. S327-S327. 2014
- The Relationship of ARMS2 Genotype with Idiopathic Inflammatory Vasculitis.. Arthritis & Rheumatology. S1245-S1246. 2014
- The Role of Macrophage Migration Inhibitory Factor (MIF) and MIF Gene Polymorphisms in the Pathogenesis of Granulomatosis with Polyangiitis.. Arthritis & Rheumatology. S819-S819. 2014
- Training the Rheumatologists of Tomorrow: The Canadian Experience.. Arthritis & Rheumatology. S1260-S1260. 2014
- Vasculitis and Inflammatory Bowel Diseases: A Study of 32 Patients with Both Conditions and Systematic Review of the Literature.. Arthritis & Rheumatology. S352-S352. 2014
- Venothromboembolism in Large Vessel Vasculitis.. Arthritis & Rheumatology. S351-S351. 2014
- Rheumatologists of Tomorrow: One School's Story. Journal of Rheumatology. 1512-1513. 2014
- Staphylococcus Aureus Infection following Facet Joint Injection Masquerading as Acute Polyarthritis and Polymyalgia Rheumatica. Journal of Rheumatology. 1483-1484. 2014
- SAT0576 Creating New Rheumatologists: the Canadian Experience. Annals of the Rheumatic Diseases. 798.3-799. 2014
- Cardiac Involvement In Granulomatosis With Polyangiitis. Arthritis and Rheumatism. S312-S312. 2013
- Clinical Value Of Commonly-Measured Laboratory Tests In Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss). Arthritis and Rheumatism. S319-S319. 2013
- Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss Syndrome): Comparison Of The Independent French Vasculitis Study Group and Italian-Pisa Patient Cohorts and Cross-Validation Of Cluster Analysis. Arthritis and Rheumatism. S321-S321. 2013
- Serum S100A8/S100A9 and S100A12 As a Marker Of Disease Activity In Giant Cell Arteritis. Arthritis and Rheumatism. S706-S706. 2013
- The Birmingham Vasculitis Activity Score As a Measure Of Disease Activity In Patients With Giant Cell Arteritis. Arthritis and Rheumatism. S707-S707. 2013
- Clinical value of commonly measured laboratory tests in eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Presse Medicale. 697-698. 2013
- Granulomatosis with polyangiitis (Wegener's) is associated with HLA-DPB1*04 and EMA6A gene variants. Evidence from a genome-wide analysis. Presse Medicale. 668-668. 2013
- Serum biomarkers during relapsing disease in eosinophilic granulomatosis with polyangiitis. Presse Medicale. 700-701. 2013
- New Disease Manifestations After Diagnosis in Six Types of Vasculitis.. Arthritis and Rheumatism. S1007-S1007. 2012
- Urinary Biomarkers in Vasculitis Associated with Anti-Neutrophil Cytoplasmic Antibodies.. Arthritis and Rheumatism. S1010-S1010. 2012
- Clinical and Serological Correlates of Systemic Sclerosis Sine Scleroderma: Findings from a Canadian Cohort. Journal of Rheumatology. 1724-1724. 2012
- Are Patients with ANCA-Associated Vasculitis Entered In Clinical Trials Representative of Patients Followed In Observational Cohorts?. Arthritis and Rheumatism. S923-S923. 2011
- Distribution of Large Artery Lesions in Takayasu's Arteritis Compared to Giant Cell Arteritis. Arthritis and Rheumatism. S587-S588. 2011
- Relapses Among Patients with Giant Cell Arteritis.. Arthritis and Rheumatism. S591-S592. 2011
- Amyloidosis and GCA/PMR: Case Report of a Rare Association. Journal of Rheumatology. 1176-1176. 2011
- Giant Cell Arteritis and MRI Evaluation of the Cranial Arteries. Journal of Rheumatology. 1138-1138. 2011
- Panniculitis/Fasciitis due to a Drug-Induced Neutrophilic Dermatosis: A case report. Journal of Rheumatology. 1182-1182. 2011
- Are patients with anti-ANCA-AAV entered into clinical trials representative of patients followed in observational cohorts?. Clinical and Experimental Immunology. 81-82. 2011
- Association between vascular physical examination findings and arteriographic lesions in subjects with LVV. Clinical and Experimental Immunology. 116-116. 2011
- Distribution of thoracic large arterial lesions in TA compared to GCA. Clinical and Experimental Immunology. 115-115. 2011
- IgA and IgG ANCAs modulate disease severity in a genetically dependent fashion. Clinical and Experimental Immunology. 77-78. 2011
- Measurement of health-related quality of life among patients with ANCA-AAV using the SF-36. Clinical and Experimental Immunology. 83-83. 2011
- Back to the Bedside - A Case of Systemic Lupus Erythematosus Associated with pANCA, cANCA and Anti-Scl Antibodies - Distilling the Diagnostic Dilemma and Literature Review. Journal of Rheumatology. 1316-1316. 2010
- Giant Cell Arteritis and MRI Evaluation of the Cranial Arteries. Journal of Rheumatology. 1283-1284. 2010
- Temporal Artery Biopsy... Does Length Really Matter?. Journal of Rheumatology. 1325-1326. 2010
- Use of Oral Contraceptive Pills in Patients with SLE - A Survey of Rheumtologists in Canada. Journal of Rheumatology. 1325-1325. 2010
- Ultrasound of the Hands and Feet: Effect on Rheumatologists' Diagnostic Confidence and Patient Management. Journal of Rheumatology. 2600-2600. 2009
- Angiopoietin-2 as a biomarker in ANCA-associated vasculitis. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 112-113. 2009
- Imaging of Large and Medium-Sized Vessel Vasculitis. American Journal of Roentgenology. 2009
- Ultrasound of the Hands and Feet: Effect on Rheumatologists' Diagnostic Confidence and Patient Management. American Journal of Roentgenology. 2009
- Decreasing Hospital Stay in Wegener's Granulomatosis - Analysis of a Tertiary Center Inpatient Experience.. Arthritis and Rheumatism. 4023-4024. 2008
- Assessment of reproductive history in systemic sclerosis. Arthritis and Rheumatism. S827-S827. 2008
- Malnutirition is common in systemic sclerosis: Results from the Canadian scleroderma research group database. Arthritis and Rheumatism. S381-S381. 2008
- Adherence to guidelines for the detection of pulmonary hypertension in patients with scleroderma. Journal of Rheumatology. 1180-1180. 2008
- CNS Wegener's granulomatosis presenting with Bell's palsy. Journal of Rheumatology. 1203-1203. 2008
- Factors associated with physician service use in systemic sclerosis. Journal of Rheumatology. 1172-1173. 2008
- MRI evaluation of scalp artery inflammation in patients with giant cell arteritis. Journal of Rheumatology. 1216-1217. 2008
- Oral contraceptives and systemic lupus erythematosus, current practice in Hamilton. Journal of Rheumatology. 1192-1192. 2008
- Resident evaluations: The use of evaluation cards in rheumatology ambulatory care. Journal of Rheumatology. 1201-1201. 2008
- Wegener's granulomatosis - Analysis of the Hamilton inpatient experience. Journal of Rheumatology. 1208-1208. 2008
- An algorithm for cardiopulmonary testing in systemic sclerosis. Annals of the Rheumatic Diseases. 200-200. 2007
- Corticosteroids in chikungunya viral polyarthritis in two Canadian travelers. Journal of Rheumatology. 1633-1633. 2007
- Knowledge dissemination strategies translate into improved post-fracture osteoporosis care. Journal of Bone and Mineral Research. S264-S264. 2005
-
journal articles
- Plasma proteome profiling in giant cell arteritis. Annals of the Rheumatic Diseases. 83:1762-1772. 2024
- Minimal Detectable Changes of the Health Assessment Questionnaire-Disability Index, Patient-Reported Outcomes Measurement Information System-29 Profile Version 2.0 Domains, and Patient Health Questionnaire-8 in People With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Cross-Sectional Study.. Arthritis Care and Research. 76:1549-1557. 2024
- A study of implementation factors for a novel approach to clinical trials: constructs for consideration in the coordination of direct-to-patient online-based medical research.. BMC Medical Research Methodology. 24:244. 2024
- Signal Regulatory Protein α Expression in Systemic Vasculitis. ACR Open Rheumatology. 6:634-640. 2024
- The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort study.. The Lancet Rheumatology. 6:e684-e692. 2024
- Vessel wall MRI in giant cell arteritis: standardized protocol and scoring approach developed by an international working group.. Rheumatology. keae498. 2024
- Risk of Relapse of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids. Arthritis & Rheumatology. 76:1431-1438. 2024
- Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study. Arthritis & Rheumatology. 76:1120-1129. 2024
- Assessment of damage in Takayasu’s arteritis. Rheumatology. keae333. 2024
- Axial Spondyloarthritis: Does Magnetic Resonance Imaging Classification Improve Report Interpretation. Journal of Clinical Rheumatology. 30:145-150. 2024
- Experiences of telehealth during and after the COVID-19 pandemic and preferences for future care of people with systemic sclerosis: a cross-sectional study. The Lancet Rheumatology. 6:e660-e663. 2024
- Moderators of Loneliness Trajectories in People with Systemic Sclerosis During the COVID-19 Pandemic: A SPIN COVID-19 Cohort Longitudinal Study. International Journal of Behavioral Medicine. 31:352-362. 2024
- Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study. The Lancet Rheumatology. 6:e374-e383. 2024
- Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study. The Lancet Rheumatology. 6:e374-e383. 2024
- Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study. Journal of Neurology. 271:3309-3320. 2024
- Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS). American Journal of Respiratory and Critical Care Medicine. 209:1141-1151. 2024
- Organic solvent exposure and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group registry. Journal of American Academy of Dermatology. 90:605-607. 2024
-
The Association Between Age at Diagnosis and Disease Characteristics and Damage in Patients With
ANCA‐Associated Vasculitis. Arthritis & Rheumatology. 75:2216-2227. 2023 - Factors affecting the discrepancy between patient and physician global assessment in early rheumatoid arthritis: The Ontario Best Practices Research Initiative.. Clinical and Experimental Rheumatology. 41:2249-2256. 2023
-
Validity, Reliability, and Differential Item Functioning of English and French Versions of the
10‐Item Connor‐Davidson Resilience Scale in Systemic Sclerosis: A SclerodermaPatient‐Centered Intervention Network Cohort Study. Arthritis Care and Research. 75:2369-2378. 2023 -
Evaluation of Measurement Properties and Differential Item Functioning in the English and French Versions of the University of California, Los Angeles, Loneliness Scale‐6: A Scleroderma
Patient‐Centered Intervention Network (SPIN ) Study. Arthritis Care and Research. 75:2158-2165. 2023 - Mitochondrial-mediated inflammation and platelet activation in giant cell arteritis. Clinical Immunology. 255:109746-109746. 2023
- Autoinflammatory gene mutations associated with eosinophilia and asthma. Allergy, Asthma and Clinical Immunology. 19:76. 2023
- CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendum. Rheumatology. 62:2646-2651. 2023
- Patterns of patient-reported symptoms and association with sociodemographic and systemic sclerosis disease characteristics: a scleroderma Patient-centered Intervention Network (SPIN) Cohort cross-sectional study. EClinicalMedicine. 62:102104-102104. 2023
- Duration of Steroid Therapy and Temporal Artery Biopsy Positivity in Giant Cell Arteritis: A Retrospective Cohort Study. Journal of Rheumatology. 50:965-966. 2023
- Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial. Annals of the Rheumatic Diseases. 82:937-944. 2023
- Added diagnostic yield of temporal artery magnetic resonance angiography in the evaluation of giant cell arteritis. Rheumatology. 62:2197-2202. 2023
- Health Care Utilization in Systemic Sclerosis Patients With Digital Ulcers. Arthritis Care and Research. 75:1071-1078. 2023
- Neutrophil extracellular trap formation in anti-neutrophil cytoplasmic antibody-associated and large-vessel vasculitis. Clinical Immunology. 249:109274-109274. 2023
-
Damage Trajectories in Systemic Sclerosis Using
Group‐Based Trajectory Modeling. Arthritis Care and Research. 75:640-647. 2023 - Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study. The Lancet Respiratory Medicine. 11:87-96. 2023
- Vitamin D status in ANCA-associated vasculitis. Rheumatology Advances in Practice. 7:rkad021. 2022
- Randomized controlled trial of an internet-based self-guided hand exercise program to improve hand function in people with systemic sclerosis: the Scleroderma Patient-centered Intervention Network Hand Exercise Program (SPIN-HAND) trial. Trials. 23:994. 2022
- 2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis. Arthritis & Rheumatology. 74:1881-1889. 2022
- 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis.. Arthritis & Rheumatology. 81:1654-1660. 2022
- Airway autoantibodies are determinants of asthma severity. European Respiratory Journal. 60:2200442-2200442. 2022
- Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis. Respiratory Research. 23:54. 2022
- Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis. Arthritis Research & Therapy. 24:160. 2022
- Geographical distribution of systemic sclerosis in Canada: An ecologic study based on the Canadian Scleroderma Research Group. Journal of American Academy of Dermatology. 87:1095-1097. 2022
- Severe ophthalmic involvement in granulomatosis with polyangiitis resistant to cyclophosphamide. Canadian Journal of Ophthalmology. 57:e162-e162. 2022
- Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT. Health Technology Assessment. 26:1-60. 2022
- Hypothyroidism in vasculitis. Rheumatology. 61:2942-2950. 2022
- Self-Reported Data and Physician-Reported Data in Patients With Eosinophilic Granulomatosis With Polyangiitis: Comparative Analysis. Interactive Journal of Medical Research. 11:e27273-e27273. 2022
- Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry. Journal of Rheumatology. 49:447-453. 2022
- Benralizumab's anti-eosinophil efficacy may be decreased by impaired NK cell activity. European Respiratory Journal. 59:2102210-2102210. 2022
- Variations in Takayasu arteritis characteristics in a cohort of patients with different racial backgrounds. Seminars in Arthritis and Rheumatism. 53:151971-151971. 2022
- 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis. Arthritis & Rheumatology. 74:386-392. 2022
- 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis.. Arthritis & Rheumatology. 81:315-320. 2022
- 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis.. Arthritis & Rheumatology. 81:321-326. 2022
- Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program. Pilot and Feasibility Studies. 8:45. 2022
- A196 DIARRHEA AS A PRESENTING SYMPTOM OF RELAPSED GRANULOMATOSIS WITH POLYANGIITIS. Journal of the Canadian Association of Gastroenterology. 5:81-82. 2022
- Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort. PLoS ONE. 17:e0274264-e0274264. 2022
- Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts. Journal of Rheumatology. 49:16-25. 2022
- Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis. Chest. 160:2158-2162. 2021
- Pain levels and associated factors in the Scleroderma Patient-centered Intervention Network (SPIN) cohort: a multicentre cross-sectional study. The Lancet Rheumatology. 3:e844-e854. 2021
- The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial. Trials. 22:856. 2021
- Value of second opinion subspecialty radiology consultation in suspected abdominal medium vessel vasculitis. Abdominal Radiology. 46:5763-5771. 2021
- Fecal microbiome differs between patients with systemic sclerosis with and without small intestinal bacterial overgrowth. Journal of Scleroderma and Related Disorders. 6:290-298. 2021
- Contextualizing temporal arterial magnetic resonance angiography in the diagnosis of giant cell arteritis: a retrospective cohort study. Rheumatology. 60:4229-4237. 2021
- Clinical Manifestations and Long‐Term Outcomes of Eosinophilic Granulomatosis With Polyangiitis in North America. ACR Open Rheumatology. 3:404-412. 2021
- Esophageal Obstruction Secondary to Massive Tumoral Calcinosis. Journal of Rheumatology. 48:786-786. 2021
- CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update. Journal of Rheumatology. 48:555-566. 2021
- Sequence‐Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2. Arthritis & Rheumatology. 73:512-519. 2021
- Association between age at disease onset of anti-neutrophil cytoplasmic antibody–associated vasculitis and clinical presentation and short-term outcomes. Rheumatology. 60:617-628. 2021
- Efficacy of leflunomide in the treatment of vasculitis. Clinical and Experimental Rheumatology. 39:S114-S118. 2021
- Factors associated with fears due to COVID-19: A Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 cohort study. Journal of Psychosomatic Research. 140:110314-110314. 2021
- Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study. American Journal of Human Genetics. 108:84-99. 2021
- Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study. Journal of Psychosomatic Research. 139:110262-110262. 2020
- Immunosuppressive treatment in diffuse cutaneous systemic sclerosis is associated with an improved composite response index (CRISS). Arthritis Research & Therapy. 22:132. 2020
- Patterns of Arterial Disease in Takayasu Arteritis and Giant Cell Arteritis. Arthritis Care and Research. 72:1615-1624. 2020
- Involvement of the intracranial circulation in giant cell arteritis. Canadian Journal of Ophthalmology. 55:391-400. 2020
- Updates in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis: At a crossroad. Presse Medicale. 49:104038-104038. 2020
- Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis. Annals of the Rheumatic Diseases. 79:1243-1249. 2020
- Characteristics of Takayasu Arteritis Patients with Severe Ischemic Events. Journal of Rheumatology. 47:1224-1228. 2020
- Patterns of clinical presentation in Takayasu's arteritis. Seminars in Arthritis and Rheumatism. 50:576-581. 2020
- Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients. Journal of Psychosomatic Research. 135:110132-110132. 2020
- Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of Vasculitis. Journal of Rheumatology. 47:1001-1010. 2020
- Mammalian target of rapamycin is activated in the kidneys of patients with scleroderma renal crisis. Journal of Scleroderma and Related Disorders. 5:152-158. 2020
- THU0318 PATTERNS OF CLINICAL PRESENTATION IN TAKAYASU’S ARTERITIS. Annals of the Rheumatic Diseases. 79:388.1-388. 2020
- Derivation of an angiographically based classification system in Takayasu’s arteritis: an observational study from India and North America. Rheumatology. 59:1118-1127. 2020
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. New England Journal of Medicine. 382:622-631. 2020
- Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severity. Rheumatology. 59:398-406. 2020
- Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrology Dialysis Transplantation. 35:283-291. 2020
- Methods for shortening patient-reported outcome measures. Statistical Methods in Medical Research. 28:2992-3011. 2019
- Collection of antirheumatic medication data from both patients and rheumatologists shows strong agreement in a real-world clinical cohort: the Ontario Best Practices Research Initiative—a rheumatoid arthritis cohort. Journal of Clinical Epidemiology. 114:95-103. 2019
- Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort Results. Journal of Rheumatology. 46:874-886. 2019
- Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System in Systemic Vasculitis. Journal of Rheumatology. 46:928-934. 2019
- Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis. Annals of the Rheumatic Diseases. 78:807-816. 2019
- Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality. Rheumatology. 58:636-644. 2019
- 020. IDENTIFICATION OF TARGET ANTIGENS FOR ANTI-ENDOTHELIAL CELL ANTIBODIES IN PATIENTS WITH TAKAYASU’S ARTERITIS USING PROTEOMICS. Rheumatology. 58:kez057.019. 2019
- 035. CANDIDATE BIOMARKERS IN ANCA-ASSOCIATED VASCULITIS IDENTIFIED USING A PROTEOMIC APPROACH. Rheumatology. 58:kez057.034. 2019
- 043. SUBGLOTTIC STENOSIS AND ENDOBRONCHIAL DISEASE IN GRANULOMATOSIS WITH POLYANGIITIS. Rheumatology. 58:kez057.042. 2019
- 045. EVALUATION OF NOVEL SERUM BIOMARKERS OF DISEASE ACTIVITY IN GIANT CELL ARTERITIS, TAKAYASU’S ARTERITIS, POLYARTERITIS NODOSA, AND EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS. Rheumatology. 58:kez057.044. 2019
- 083. COMPARISON OF ARTERIAL PATTERNS OF DISEASE IN TAKAYASU’S ARTERITIS AND GIANT CELL ARTERITIS. Rheumatology. 58:kez058.023. 2019
- 084. DISCOVERY AND VALIDATION OF A NOVEL ANGIOGRAPHIC CLASSIFICATION SCHEME IN TAKAYASU’S ARTERITIS. Rheumatology. 58:kez058.024. 2019
- 090. A CLINICAL SCORING SYSTEM FOR RISK STRATIFICATION OF GIANT CELL ARTERITIS. Rheumatology. 58:kez058.030. 2019
- 138. DIFFUSE ALVEOLAR HEMORRHAGE, PULMONARY NODULES AND INFILTRATES IN GRANULOMATOSIS POLYANGIITIS AND MICROSCOPIC POLYANGIITIS. A COHORT STUDY OF 736 PATIENTS. Rheumatology. 58:kez059.015. 2019
- 139. UTILIZATION OF CANADIAN HEALTHCARE ADMINISTRATIVE DATABASES TO ACCURATELY IDENTIFY CASES OF ANCA-ASSOCIATED VASCULITIS. Rheumatology. 58:kez059.016. 2019
- 148. SHORT-FORM 36 AS A MEASURE OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH GIANT CELL ARTERITIS. Rheumatology. 58:kez059.025. 2019
- 275. FACTORS ASSOCIATED WITH DISEASE PROGRESSION IN PATIENTS WITH MYELOPEROXIDASE-ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-RELATED PULMONARY FIBROSIS. Rheumatology. 58:kez062.049. 2019
- Arterial lesions in giant cell arteritis: A longitudinal study. Seminars in Arthritis and Rheumatism. 48:707-713. 2019
- Presentation and Disease Course of Childhood‐Onset Versus Adult‐Onset Takayasu Arteritis. Arthritis & Rheumatology. 71:315-323. 2019
- Shortening patient-reported outcome measures through optimal test assembly: application to the Social Appearance Anxiety Scale in the Scleroderma Patient-centered Intervention Network Cohort. BMJ Open. 9:e024010-e024010. 2019
- Sputum Antineutrophil Cytoplasmic Antibodies in Serum Antineutrophil Cytoplasmic Antibody–Negative Eosinophilic Granulomatosis with Polyangiitis. American Journal of Respiratory and Critical Care Medicine. 199:158-170. 2019
- <p>Neural network and logistic regression diagnostic prediction models for giant cell arteritis: development and validation</p>. Clinical Ophthalmology. Volume 13:421-430. 2019
- Serum cytokine and chemokine levels in patients with eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, or eosinophilic asthma. Clinical and Experimental Rheumatology. 37:S40-S44. 2019
- Serum cytokine and chemokine levels in patients with eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, or eosinophilic asthma.. Clinical and Experimental Rheumatology. 37 Suppl 117:40-44. 2019
- ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI). RMD Open. 4:e000738-e000738. 2018
- Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient‐Centered Intervention Network Cohort Study. Arthritis Care and Research. 70:1646-1652. 2018
- Interstitial lung disease is associated with an increased risk of lung cancer in systemic sclerosis: Longitudinal data from the Canadian Scleroderma Research Group. Journal of Scleroderma and Related Disorders. 3:221-227. 2018
- Serum S100 Proteins as a Marker of Disease Activity in Large Vessel Vasculitis. Journal of Clinical Rheumatology. 24:393-395. 2018
- Validation of the Social Appearance Anxiety Scale in Patients With Systemic Sclerosis: A Scleroderma Patient‐Centered Intervention Network Cohort Study. Arthritis Care and Research. 70:1557-1562. 2018
- The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts. Rheumatology. 57:1623-1631. 2018
- LB01THE EFFECT OF PLASMA EXCHANGE ON END STAGE RENAL DISEASE AND DEATH IN PATIENTS WITH SEVERE ANCA ASSOCIATED VASCULITIS. Nephrology Dialysis Transplantation. 33:i636-i636. 2018
- LB02THE EFFECT OF REDUCED-DOSE GLUCOCORTICOIDS DURING REMISSION INDUCTION IN SEVERE ANCA ASSOCIATED VASCULITIS. Nephrology Dialysis Transplantation. 33:i636-i636. 2018
- Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype. Autoimmunity Reviews. 17:267-275. 2018
- Evaluation of damage in giant cell arteritis. Rheumatology. 57:322-328. 2018
- Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network hand exercise program (SPIN-HAND): Study protocol. Journal of Scleroderma and Related Disorders. 3:91-97. 2018
- Validation of the Social Interaction Anxiety Scale in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort study. Journal of Scleroderma and Related Disorders. 3:98-105. 2018
- Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy. Allergy, Asthma and Clinical Immunology. 13:2. 2017
- Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise. Journal of Rheumatology. 44:1928-1932. 2017
- What have multicentre registries across the world taught us about the disease features of systemic sclerosis?. Journal of Scleroderma and Related Disorders. 2:169-182. 2017
- Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort. Rheumatology. 56:1111-1122. 2017
- Early Mortality in a Multinational Systemic Sclerosis Inception Cohort. Arthritis & Rheumatology. 69:1067-1077. 2017
- Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis. Arthritis & Rheumatology. 69:1054-1066. 2017
- Correction: Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy. Scientific Reports. 7:46012. 2017
- A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Giant Cell Arteritis. Arthritis & Rheumatology. 69:837-845. 2017
- A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Takayasu Arteritis. Arthritis & Rheumatology. 69:846-853. 2017
- Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues. Rheumatology. 56:kew441-kew441. 2017
- Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy. Scientific Reports. 7:43953. 2017
- IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Clinical and Experimental Rheumatology. 35:S98-S101. 2017
- Validation of the Body Concealment Scale for Scleroderma (BCSS): Replication in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort. Body Image. 20:99-106. 2017
- WS1_1 Sputum Anti-neutrophil Cytoplasmic Antibodies (ANCA) in Eosinophilic Granulamatosis and Polyangiitis (eGPA). Rheumatology. 56:iii17-iii19. 2017
- Experience With Direct-to-Patient Recruitment for Enrollment Into a Clinical Trial in a Rare Disease: A Web-Based Study. Journal of Medical Internet Research. 19:e50-e50. 2017
- Reply. Arthritis & Rheumatology. 69:477-478. 2017
- The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients. Clinical Rheumatology. 36:373-379. 2017
- A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis. American Journal of Human Genetics. 100:64-74. 2017
- ANCA-associated pauci-immune glomerulonephritis in a patient with bacterial endocarditis: a challenging clinical dilemma. Clinical Nephrology - Case Studies. 5:32-37. 2017
- High‐Resolution Magnetic Resonance Imaging of Scalp Arteries for the Diagnosis of Giant Cell Arteritis: Results of a Prospective Cohort Study. Arthritis & Rheumatology. 69:161-168. 2017
- IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss).. Clinical and Experimental Rheumatology. 35 Suppl 103:98-101. 2017
- Relationship between calcium channel blockers and skin fibrosis in patients with systemic sclerosis.. Clinical and Experimental Rheumatology. 35 Suppl 106:56-60. 2017
- The Comparability of Functional Assessment of Chronic Illness Therapy - Fatigue Scores between Cancer and Systemic Sclerosis. Journal of Scleroderma and Related Disorders. 2:57-63. 2017
- Calcinosis is associated with digital ischaemia in systemic sclerosis—a longitudinal study. Rheumatology. 55:2148-2155. 2016
- Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients. Arthritis Research & Therapy. 18:20. 2016
- Using Optimal Test Assembly Methods for Shortening Patient‐Reported Outcome Measures: Development and Validation of the Cochin Hand Function Scale‐6: A Scleroderma Patient‐Centered Intervention Network Cohort Study. Arthritis Care and Research. 68:1704-1713. 2016
- An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial. Journal of Rheumatology. 43:1672-1679. 2016
- P086 <break /> Prevalence of finger clubbing in Interstitial Lung Diseases. QJM - Monthly Journal of the Association of Physicians. 109:s51-s51. 2016
- Subsets in systemic sclerosis: one size does not fit all. Journal of Scleroderma and Related Disorders. 1:298-306. 2016
- Development and Validation of the Body Concealment Scale for Scleroderma. Arthritis Care and Research. 68:1158-1165. 2016
- Using Marital Status and Continuous Marital Satisfaction Ratings to Predict Depressive Symptoms in Married and Unmarried Women With Systemic Sclerosis: A Canadian Scleroderma Research Group Study. Arthritis Care and Research. 68:1143-1149. 2016
- Validation of the Self‐Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient‐Centered Intervention Network Cohort Study. Arthritis Care and Research. 68:1195-1200. 2016
- The Impact of Pain and Itch on Functioning and Health-Related Quality of Life in Systemic Sclerosis: An Exploratory Study. Journal of Pain and Symptom Management. 52:43-53. 2016
- The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell Arteritis. Journal of Rheumatology. 43:1078-1084. 2016
- How to Attract Trainees, a Pan-Canadian Perspective: Phase 1 of the “Training the Rheumatologists of Tomorrow” Project. Journal of Rheumatology. 43:788-798. 2016
- Severe Intracranial Involvement in Giant Cell Arteritis: 5 Cases and Literature Review. Journal of Rheumatology. 43:648-656. 2016
- Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature. Seminars in Arthritis and Rheumatism. 45:475-482. 2016
- CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides. Journal of Rheumatology. 43:97-120. 2016
- Examination of the association of sex and race/ethnicity with appearance concerns: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort study.. Clinical and Experimental Rheumatology. 34 Suppl 100:92-99. 2016
- Polyarteritis nodosa – Challenges and options in management. Indian Journal of Rheumatology. 10:S64-S71. 2015
- Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects. Autoimmunity. 48:542-551. 2015
- Thinking outside the box—The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect. Seminars in Arthritis and Rheumatism. 45:184-189. 2015
- Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis. Rheumatology. 54:1351-1359. 2015
- Cardiac Involvement in Granulomatosis with Polyangiitis. Journal of Rheumatology. 42:1209-1212. 2015
- Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study. Journal of Rheumatology. 42:1213-1217. 2015
- Antinuclear antibody-negative systemic sclerosis. Seminars in Arthritis and Rheumatism. 44:680-686. 2015
- Identification of Susceptibility Loci in IL6, RPS9/LILRB3, and an Intergenic Locus on Chromosome 21q22 in Takayasu Arteritis in a Genome‐Wide Association Study. Arthritis & Rheumatology. 67:1361-1368. 2015
- Development of Canadian Recommendations for the Management of ANCA-Associated Vasculitides: Results of the National Needs Assessment Questionnaire. Open Rheumatology Journal. 9:16-20. 2015
- 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis Outperform the 1980 Criteria: Data From the Canadian Scleroderma Research Group. Arthritis Care and Research. 67:582-587. 2015
- A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility. American Journal of Human Genetics. 96:565-580. 2015
- Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts. Clinical and Experimental Rheumatology. 33:S77-S83. 2015
- CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody (ANCA)-Associated Vasculitides – Executive Summary. Canadian Journal of Kidney Health and Disease. 2:78-78. 2015
- Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts.. Clinical and Experimental Rheumatology. 33:S-77-83. 2015
- Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival.. Clinical and Experimental Rheumatology. 33:S131-S135. 2015
- Serum Biomarkers in Patients with Relapsing Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss). PLoS ONE. 10:e0121737-e0121737. 2015
- Systemic Sclerosis Sine Scleroderma: A Multicenter Study of 1417 Subjects. Journal of Rheumatology. 41:2179-2185. 2014
- Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis—Results from the International Scleroderma Renal Crisis Survey. Seminars in Arthritis and Rheumatism. 43:666-672. 2014
- Effect of menopause on the modified Rodnan skin score in systemic sclerosis. Arthritis Research & Therapy. 16:R130-R130. 2014
- Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis. American Journal of Human Genetics. 94:47-61. 2014
- Systemic Sclerosis Immunoglobulin Induces Growth and a Pro-Fibrotic State in Vascular Smooth Muscle Cells through the Epidermal Growth Factor Receptor. PLoS ONE. 9:e100035-e100035. 2014
- New Features of Disease After Diagnosis in 6 Forms of Systemic Vasculitis. Journal of Rheumatology. 40:1905-1912. 2013
- MR Imaging of the Spine and Sacroiliac Joints for Spondyloarthritis: Influence on Clinical Diagnostic Confidence and Patient Management. Radiology. 269:208-215. 2013
- Association of Granulomatosis With Polyangiitis (Wegener's) With HLA–DPB1*04 and SEMA6A Gene Variants: Evidence From Genome‐Wide Analysis. Arthritis and Rheumatism. 65:2457-2468. 2013
- The 15% Rule in Scleroderma: The Frequency of Severe Organ Complications in Systemic Sclerosis. A Systematic Review. Journal of Rheumatology. 40:1545-1556. 2013
- Hypertensive Retinopathy in Takayasu Arteritis. Neuro-Ophthalmology. 37:157-158. 2013
- Identification of Multiple Genetic Susceptibility Loci in Takayasu Arteritis. American Journal of Human Genetics. 93:298-305. 2013
- Association of Gastroesophageal Factors and Worsening of Forced Vital Capacity in Systemic Sclerosis. Journal of Rheumatology. 40:850-858. 2013
- Radiology–pathology conference: neutrophilic fasciitis and panniculitis of the feet (Sweet's syndrome). Clinical Imaging. 37:608-612. 2013
- Urinary Biomarkers in Relapsing Antineutrophil Cytoplasmic Antibody-associated Vasculitis. Journal of Rheumatology. 40:674-683. 2013
- Does cigarette smoking mitigate the severity of skin disease in systemic sclerosis?. Rheumatology International. 33:943-948. 2013
- Longitudinal Study of Renal Function in Systemic Sclerosis. Journal of Rheumatology. 39:1829-1834. 2012
- Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis. Annals of the Rheumatic Diseases. 71:1329-1334. 2012
- Amyloidosis and Giant Cell Arteritis/Polymyalgia Rheumatica. Journal of Rheumatology. 39:878-880. 2012
- Clinical Correlates of CENP-A and CENP-B Antibodies in a Large Cohort of Patients with Systemic Sclerosis. Journal of Rheumatology. 39:787-794. 2012
- Agreement with Guidelines from a Large Database for Management of Systemic Sclerosis: Results from the Canadian Scleroderma Research Group. Journal of Rheumatology. 39:524-531. 2012
- Assessment of health‐related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's). Arthritis Care and Research. 64:273-279. 2012
- Association of Vascular Physical Examination Findings and Arteriographic Lesions in Large Vessel Vasculitis. Journal of Rheumatology. 39:303-309. 2012
- Circulating Angiopoietin-2 as a Biomarker in ANCA-Associated Vasculitis. PLoS ONE. 7:e30197-e30197. 2012
- IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis. Proceedings of the National Academy of Sciences of the United States of America. 108:20736-20741. 2011
- Measuring Pain in Systemic Sclerosis: Comparison of the Short-form McGill Pain Questionnaire Versus a Single-item Measure of Pain. Journal of Rheumatology. 38:2581-2587. 2011
- Anti-Fibrillarin Antibody in African American Patients with Systemic Sclerosis: Immunogenetics, Clinical Features, and Survival Analysis. Journal of Rheumatology. 38:1622-1630. 2011
- Antiphospholipid Syndrome and the Aorta: A Rare Presentation. Journal of Rheumatology. 38:1808-1809. 2011
- ANCA-associated Vasculitides and Classification: A Conundrum Solved?. Journal of Rheumatology. 38:971-972. 2011
- Disability in Systemic Sclerosis — A Longitudinal Observational Study. Journal of Rheumatology. 38:685-692. 2011
- Observational Data to Study Medication Outcomes in Systemic Sclerosis: Table 1.. Journal of Rheumatology. 38:575.2-577. 2011
- The Effects of Needleless Connectors on Catheter-Related Thrombotic Occlusions. Journal of Infusion Nursing. 34:89-96. 2011
- Discordance between Patient and Physician Assessments of Disease Severity in Systemic Sclerosis. Journal of Rheumatology. 37:2307-2312. 2010
- The Association Between Disease Activity and Duration in Systemic Sclerosis. Journal of Rheumatology. 37:2299-2306. 2010
- Association of pruritus with quality of life and disability in systemic sclerosis. Arthritis Care and Research. 62:1489-1495. 2010
- Correction: Oral Contraceptives and Systemic Lupus Erythematosus, Current Practice in Hamilton. Journal of Rheumatology. 37:1788.2-1788. 2010
- Role of ultrasound in the management of rheumatological conditions of the hands and feet. International Journal of Clinical Rheumatology. 5:147-149. 2010
- Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis. Arthritis Care and Research. 62:409-417. 2010
- The Minimally Important Difference in Clinical Practice for Patient-centered Outcomes Including Health Assessment Questionnaire, Fatigue, Pain, Sleep, Global Visual Analog Scale, and SF-36 in Scleroderma. Journal of Rheumatology. 37:591-598. 2010
- Prevalence and clinical correlates of pruritus in patients with systemic sclerosis. Arthritis and Rheumatism. 61:1765-1770. 2009
- Closing the osteoporosis care gap – Increased osteoporosis awareness among geriatrics and rehabilitation teams. BMC Geriatrics. 9:28. 2009
- Malnutrition Is Common in Systemic Sclerosis: Results from the Canadian Scleroderma Research Group Database. Journal of Rheumatology. 36:2737-2743. 2009
- Catastrophic Antiphospholipid Syndrome and Polyarteritis Nodosa. Journal of Rheumatology. 36:2619-2621. 2009
- Ultrasound of the hands and feet for rheumatological disorders: influence on clinical diagnostic confidence and patient management. Skeletal Radiology. 38:1049-1054. 2009
- Work Disability in Systemic Sclerosis. Journal of Rheumatology. 36:2481-2486. 2009
- Health‐related quality of life in systemic sclerosis: A systematic review. Arthritis and Rheumatism. 61:1112-1120. 2009
- Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: Evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients. Arthritis and Rheumatism. 61:966-973. 2009
- Bilateral tight swollen legs. Skeletal Radiology. 38:709-710. 2009
- Bilateral tight swollen legs: diagnosis and discussion. Skeletal Radiology. 38:729-730. 2009
- Validity of Self-Reported Comorbidities in Systemic Sclerosis: Table 1.. Journal of Rheumatology. 36:1477-1480. 2009
- Resident Evaluations: The Use of Daily Evaluation Forms in Rheumatology Ambulatory Care. Journal of Rheumatology. 36:1298-1303. 2009
- Role of Ultrasound in the Assessment of Small-Joint Synovitis. Canadian Association of Radiologists Journal. 60:69-70. 2009
- Reports of abnormal cervical cancer screening tests in systemic sclerosis. Rheumatology. 48:149-151. 2009
- The cost of systemic sclerosis. Arthritis and Rheumatism. 61:119-123. 2009
- Demographic and Clinical Factors Associated with Physician Service Use in Systemic Sclerosis. Journal of Rheumatology. 36:96-98. 2009
- Sensorineural hearing loss in systemic lupus erythematosus: case report and literature review. Journal of Laryngology and Otology. 122:1371-1376. 2008
- Assessment of reproductive history in systemic sclerosis. Arthritis and Rheumatism. 59:1661-1664. 2008
- Chikungunya viral polyarthritis.. Journal of Rheumatology. 35:935-936. 2008
- Churg-Strauss syndrome and revascularization of the hand: a case report.. Journal of Rheumatology. 35:941-943. 2008
- Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. Arthritis and Rheumatism. 59:504-509. 2008
- High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptoms. Arthritis and Rheumatism. 59:431-437. 2008
- Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis. Arthritis and Rheumatism. 59:438-443. 2008
- Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II. Arthritis and Rheumatism. 59:279-284. 2008
- Quality of life in systemic sclerosis: Psychometric properties of the World Health Organization Disability Assessment Schedule II. Arthritis and Rheumatism. 59:270-278. 2008
- Hypocomplementemia in systemic sclerosis--clinical and serological correlations.. Journal of Rheumatology. 34:2218-2223. 2007
- Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis.. Clinical and Experimental Rheumatology. 25:754-757. 2007
- Community-based evaluation of etanercept in patients with rheumatoid arthritis.. Journal of Rheumatology. 33:665-670. 2006
- International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis. Journal of the American Medical Association (JAMA). 295:180-180. 2006
- Coexisting Systemic Lupus Erythematosus and Sickle Cell Disease. Journal of Clinical Rheumatology. 11:86-92. 2005
- Metabolic complications of parenteral nutrition in adults, part 2. American Journal of Health-System Pharmacy. 61:2616-2616. 2004
- Recalcitrant steroid-resistant EGPA with multisystem involvement. Case Reports in Internal Medicine. 4:12-12.
-
preprints
- Autoinflammatory Gene Mutations Associated with Eosinophilia and Asthma 2023
- Biologic DMARD Access and Medication Cost-related Nonadherence in Rheumatology Patients in Canada: A Cross-sectional Survey 2023
- Self-Reported Data and Physician-Reported Data in Patients With Eosinophilic Granulomatosis With Polyangiitis: Comparative Analysis (Preprint) 2021